Search for: "Novartis Pharmaceuticals Corporation"
Results 101 - 120
of 216
Sorted by Relevance
|
Sort by Date
29 Mar 2012, 10:00 pm
Prometheus. 3) Intellectual Property Watch: Novartis India Challenge Postponed To July – This post shares how the Indian Supreme Court today postponed hearing the high-profile case involving Swiss pharmaceutical producer Novartis’ challenge of India’s patent law until July. 4) Patents Post-Grant: AIA Changes to Greatly Increase Stays of District Court Actions – This post discusses the estoppel provisions of Post Grant Review and Inter… [read post]
15 Feb 2011, 4:06 am
Unlike conventional retail sales, the patient is not at liberty to choose personally which prescription pharmaceutical he desires. [read post]
5 May 2010, 5:14 pm
Martin – FDA just released the Warning Letter it issued to Novartis Pharmaceuticals Corporation (“Novartis”) in April regarding two purportedly unbranded websites, www.gistalliance.com and www.cmlalliance.com (the “alliance websites”), which included disease-state information and clinical data about gastrointestinal stromal tumors (“GIST”) and chronic myeloid leukemia (“CML”). [read post]
18 Apr 2011, 5:51 pm
Prior to joining HP&M, Linda served in several pharmaceutical industry positions, including as Senior Director, Global Regulatory Policy and Intelligence, Janssen Pharmaceutical Companies of Johnson & Johnson, Executive Director, FDA Liaison, Drug Regulatory Affairs, Novartis Pharmaceuticals Corporation, and Director, Global Regulatory Affairs, Legislative Policy and Regulatory Liaison, Pharmacia Corporation. [read post]
12 Mar 2013, 6:20 am
Novartis Pharmaceutical Corp., 2012 WL 5398219 (Mag. [read post]
21 Nov 2017, 2:40 pm
We recommend that the FDA and [Novartis Pharmaceuticals Corporation] the manufacturer [of Entresto] more clearly communicate the full risk of hypotension, including appropriate steps for monitoring patients, and examine whether a more gradual escalation of dose to the recommended level would reduce the risk. [read post]
27 Sep 2010, 12:59 am
Karst – Just two days after Novartis Pharmaceuticals Corporation (“Novartis”) filed a Complaint in the U.S. [read post]
4 Nov 2011, 4:09 am
Novartis Pharmaceutical paid $422.5 million to settle claims it promoted its epilepsy drug, Trileptal, for off label uses. [read post]
3 Aug 2013, 6:35 am
Other significant suppliers are Ranbaxy Labs, Hetero Labs, Aurobindo Pharma, Haffkine Bio-Pharmaceutical Corporation, Biological E and Micro Labs Pharma. [read post]
10 Feb 2013, 4:00 pm
Astellas Venture Management is the corporate venture capital arm of Northbrook, Ill. [read post]
2 Feb 2009, 9:51 am
This January 2008 press release from KV Pharmaceutical, the parent company of ETHEX, includes a list of the more than 60 generic drugs being recalled by ETHEX. [read post]
24 Jan 2012, 6:34 pm
District Court for the Northern District of Illinois (Eastern Division), the court denied Plaintiffs’ Seattle Children’s Hospital, Novartis Vaccines and Diagnostics, Inc., and Novartis Pharmaceuticals Corporation (collectively “Novartis”) Motion to Dismiss the lawsuit that they brought against Akorn, Inc. [read post]
27 Jan 2021, 11:07 am
Badboy pharmaceutical giant Novartis AG and two of its subsidiaries paid the DOJ and SEC $346.7 million. [read post]
5 Jan 2021, 12:28 pm
Novartis – In July, the pharmaceutical giant agreed to pay $678 million to resolve a New York case alleging that it paid inflated “speaking fees” and provided other incentives (including lavish meals, deep-sea fishing outings, wine tastings, hibachi tables, and golf trips) to doctors to induce them to prescribe Novartis drugs. [read post]
23 Nov 2010, 2:00 pm
The largest fiscal year 2010 False Claims Act recoveries came from the pharmaceutical and medical device industries, which accounted for $1.6 billion in settlements, including the $669 million from Pfizer Inc., $302 million from AstraZeneca, and $192.7 from Novartis Pharmaceutical Corporation. [read post]
31 Dec 2013, 11:41 pm
In the US, the Court of Appeals for the Federal Circuit completely failed to come to terms with patent-eligibility of software-implemented inventions in the case of CLS Bank v Alice Corporation which is, as a consequence, now on its way to the Supreme Court.Australia’s High Court confirmed the patent-eligibility of methods of medical treatment, and in particular of methods for treating conditions using known pharmaceutical substances that have not previously been known… [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy':… [read post]
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA Inc. et al. [read post]
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA Inc. et al. [read post]
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA Inc. et al. [read post]
